The injection pen market size is USD 45.4 Bn in 2026.
The injection pen market is projected to grow at a CAGR of 6% by 2033.
The injection pen market growth drivers include rising diabetes prevalence, increasing use of insulin pens, and functional benefits of injection pens.
North America is a dominating region for the injection pen market.
Novo Nordisk A/S, Eli Lilly and Company, Sanofi, BD (Becton, Dickinson and Company), and Ypsomed AG are some leading industry players in the injection pen market.